FDA approves therapy to treat patients with relapsed and refractory mantle cell lymphoma EP News Bureau Nov 18, 2019 Mantle cell lymphoma is a type of non-Hodgkin’s lymphoma representing three to ten per cent of all non-Hodgkin’s lymphomas in the…
